Changes in metabolic profile and population of skeletal muscle fibers of mice overexpressing calsequestrin: Influence of losartan

Karla Punkt, Tina Kusche, Sophie Günther, Volker Adams, Larry Jones, Joachim Neumann

Research output: Contribution to journalArticle

Abstract

In heart failure, exertional fatigue of skeletal muscles can occur. A transgenic mouse overexpressing calsequestrin can be regarded as an animal model of heart failure. The aims of the present study were to investigate, whether at the time of cardiac failure the composition of fiber types of skeletal muscles was altered, what kind of alterations in glycolytic and oxidative enzyme activities occurred in different muscle fiber types and whether these were affected by the administration of the angiotensin II receptor blocker, losartan. Hemodynamic parameters were determined using a working heart preparation. Four groups of mice were investigated: wild-type (WT) mice and transgenic (TG) mice overexpressing calsequestrin, with and without losartan treatment. Enzyme activities were measured in homogenates of Rectus femoris muscle and in muscle fibers, which were typed by their metabolic profile. Calcineurin expression was measured by Western blotting. Succinate dehydrogenase activity was increased by 275% in R. femoris muscle homogenates of TG compared to WT mice. This was due to a 57% increase in slow oxidative fibers, which was accompanied by an increased calcineurin expression in TG muscles. This increase was attenuated by losartan treatment. With respect to glycerol-3-phosphate-dehydrogenase (GPDH), no difference was evident comparing WT and TG. Treatment with losartan resulted in a down-regulation of GPDH in WT and TG. In conclusion, changes in skeletal muscles occur in this mouse model of heart failure and these changes were antagonized by losartan. In contrast to heart failure patients, in the mouse model a shift to the oxidative phenotype of skeletal muscle was noted, possibly due to enhanced calcineurin expression.

Original languageEnglish
Pages (from-to)547-555
Number of pages9
JournalActa Histochemica
Volume113
Issue number5
DOIs
StatePublished - Sep 2011

Fingerprint

Calsequestrin
Losartan
Metabolome
Skeletal Muscle Fibers
Heart Failure
Calcineurin
Muscles
Glycerolphosphate Dehydrogenase
Skeletal Muscle
Population
Quadriceps Muscle
Transgenic Mice
Succinate Dehydrogenase
Angiotensin Receptor Antagonists
Enzymes
Fatigue
Therapeutics
Down-Regulation
Animal Models
Hemodynamics

Keywords

  • Calcineurin
  • Glycerol-3-phosphate-dehydrogenase
  • Heart failure
  • Losartan
  • Skeletal muscle
  • Succinate dehydrogenase
  • Transgenic mice

ASJC Scopus subject areas

  • Cell Biology
  • Histology

Cite this

Changes in metabolic profile and population of skeletal muscle fibers of mice overexpressing calsequestrin : Influence of losartan. / Punkt, Karla; Kusche, Tina; Günther, Sophie; Adams, Volker; Jones, Larry; Neumann, Joachim.

In: Acta Histochemica, Vol. 113, No. 5, 09.2011, p. 547-555.

Research output: Contribution to journalArticle

Punkt, Karla ; Kusche, Tina ; Günther, Sophie ; Adams, Volker ; Jones, Larry ; Neumann, Joachim. / Changes in metabolic profile and population of skeletal muscle fibers of mice overexpressing calsequestrin : Influence of losartan. In: Acta Histochemica. 2011 ; Vol. 113, No. 5. pp. 547-555.
@article{3269bbf5dfb147bf97357104edb32447,
title = "Changes in metabolic profile and population of skeletal muscle fibers of mice overexpressing calsequestrin: Influence of losartan",
abstract = "In heart failure, exertional fatigue of skeletal muscles can occur. A transgenic mouse overexpressing calsequestrin can be regarded as an animal model of heart failure. The aims of the present study were to investigate, whether at the time of cardiac failure the composition of fiber types of skeletal muscles was altered, what kind of alterations in glycolytic and oxidative enzyme activities occurred in different muscle fiber types and whether these were affected by the administration of the angiotensin II receptor blocker, losartan. Hemodynamic parameters were determined using a working heart preparation. Four groups of mice were investigated: wild-type (WT) mice and transgenic (TG) mice overexpressing calsequestrin, with and without losartan treatment. Enzyme activities were measured in homogenates of Rectus femoris muscle and in muscle fibers, which were typed by their metabolic profile. Calcineurin expression was measured by Western blotting. Succinate dehydrogenase activity was increased by 275{\%} in R. femoris muscle homogenates of TG compared to WT mice. This was due to a 57{\%} increase in slow oxidative fibers, which was accompanied by an increased calcineurin expression in TG muscles. This increase was attenuated by losartan treatment. With respect to glycerol-3-phosphate-dehydrogenase (GPDH), no difference was evident comparing WT and TG. Treatment with losartan resulted in a down-regulation of GPDH in WT and TG. In conclusion, changes in skeletal muscles occur in this mouse model of heart failure and these changes were antagonized by losartan. In contrast to heart failure patients, in the mouse model a shift to the oxidative phenotype of skeletal muscle was noted, possibly due to enhanced calcineurin expression.",
keywords = "Calcineurin, Glycerol-3-phosphate-dehydrogenase, Heart failure, Losartan, Skeletal muscle, Succinate dehydrogenase, Transgenic mice",
author = "Karla Punkt and Tina Kusche and Sophie G{\"u}nther and Volker Adams and Larry Jones and Joachim Neumann",
year = "2011",
month = "9",
doi = "10.1016/j.acthis.2010.05.009",
language = "English",
volume = "113",
pages = "547--555",
journal = "Acta Histochemica",
issn = "0065-1281",
publisher = "Urban und Fischer Verlag Jena",
number = "5",

}

TY - JOUR

T1 - Changes in metabolic profile and population of skeletal muscle fibers of mice overexpressing calsequestrin

T2 - Influence of losartan

AU - Punkt, Karla

AU - Kusche, Tina

AU - Günther, Sophie

AU - Adams, Volker

AU - Jones, Larry

AU - Neumann, Joachim

PY - 2011/9

Y1 - 2011/9

N2 - In heart failure, exertional fatigue of skeletal muscles can occur. A transgenic mouse overexpressing calsequestrin can be regarded as an animal model of heart failure. The aims of the present study were to investigate, whether at the time of cardiac failure the composition of fiber types of skeletal muscles was altered, what kind of alterations in glycolytic and oxidative enzyme activities occurred in different muscle fiber types and whether these were affected by the administration of the angiotensin II receptor blocker, losartan. Hemodynamic parameters were determined using a working heart preparation. Four groups of mice were investigated: wild-type (WT) mice and transgenic (TG) mice overexpressing calsequestrin, with and without losartan treatment. Enzyme activities were measured in homogenates of Rectus femoris muscle and in muscle fibers, which were typed by their metabolic profile. Calcineurin expression was measured by Western blotting. Succinate dehydrogenase activity was increased by 275% in R. femoris muscle homogenates of TG compared to WT mice. This was due to a 57% increase in slow oxidative fibers, which was accompanied by an increased calcineurin expression in TG muscles. This increase was attenuated by losartan treatment. With respect to glycerol-3-phosphate-dehydrogenase (GPDH), no difference was evident comparing WT and TG. Treatment with losartan resulted in a down-regulation of GPDH in WT and TG. In conclusion, changes in skeletal muscles occur in this mouse model of heart failure and these changes were antagonized by losartan. In contrast to heart failure patients, in the mouse model a shift to the oxidative phenotype of skeletal muscle was noted, possibly due to enhanced calcineurin expression.

AB - In heart failure, exertional fatigue of skeletal muscles can occur. A transgenic mouse overexpressing calsequestrin can be regarded as an animal model of heart failure. The aims of the present study were to investigate, whether at the time of cardiac failure the composition of fiber types of skeletal muscles was altered, what kind of alterations in glycolytic and oxidative enzyme activities occurred in different muscle fiber types and whether these were affected by the administration of the angiotensin II receptor blocker, losartan. Hemodynamic parameters were determined using a working heart preparation. Four groups of mice were investigated: wild-type (WT) mice and transgenic (TG) mice overexpressing calsequestrin, with and without losartan treatment. Enzyme activities were measured in homogenates of Rectus femoris muscle and in muscle fibers, which were typed by their metabolic profile. Calcineurin expression was measured by Western blotting. Succinate dehydrogenase activity was increased by 275% in R. femoris muscle homogenates of TG compared to WT mice. This was due to a 57% increase in slow oxidative fibers, which was accompanied by an increased calcineurin expression in TG muscles. This increase was attenuated by losartan treatment. With respect to glycerol-3-phosphate-dehydrogenase (GPDH), no difference was evident comparing WT and TG. Treatment with losartan resulted in a down-regulation of GPDH in WT and TG. In conclusion, changes in skeletal muscles occur in this mouse model of heart failure and these changes were antagonized by losartan. In contrast to heart failure patients, in the mouse model a shift to the oxidative phenotype of skeletal muscle was noted, possibly due to enhanced calcineurin expression.

KW - Calcineurin

KW - Glycerol-3-phosphate-dehydrogenase

KW - Heart failure

KW - Losartan

KW - Skeletal muscle

KW - Succinate dehydrogenase

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=79955484829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955484829&partnerID=8YFLogxK

U2 - 10.1016/j.acthis.2010.05.009

DO - 10.1016/j.acthis.2010.05.009

M3 - Article

C2 - 20619444

AN - SCOPUS:79955484829

VL - 113

SP - 547

EP - 555

JO - Acta Histochemica

JF - Acta Histochemica

SN - 0065-1281

IS - 5

ER -